The approval allows treatment of heart failure patients irrespective of the ejection fraction based on new trial DELIVER conducted by AstraZeneca
OncoVeryx-F, a proprietary test developed by PredOmix, is set to transform early-stage cancer detection
Acquisition enhances Freenome's product portfolio, including autoantibody platform with additional biomarkers important in cancer detection
Testing supporting allergy diagnosis now accessible to more people in more communities
PredOmix has developed a novel blood test that can detect about 32 cancers in both men and women with 98 percent accuracy
The blood test market worldwide is today around $75-80 billion
A First of its Kind Initiative in Mahbubnagar District for Medical Officers, ANM, Anganwadi workers for prevention of Thalassemia and Sickle Cell anemia as part of Antenatal screening of pregnant women project
Patients with moderate or elevated risk in the test should immediately consult a cardiologist for further diagnosis and workup
Blood test for early detection of Alzheimer's Disease (AD) risk will lead to better patient care, physicians say; US. adults call for earlier evaluation and more education
Exclusive distribution agreement brings Point-Of-Care (POC) haematology diagnostics to new regions in the Middle East
Subscribe To Our Newsletter & Stay Updated
